Setting an agenda for comparative effectiveness systematic reviews in CKD care

BMC Nephrology

L Ebony Boulware⁵  Pammie R Crawford³  Kemi A Fawole³  Jodi B Segal¹  David Doggett³  Michael J Choi²  Jeffrey J Fadrowski⁶  Raquel C Greer¹  Deidra C Crews⁴ 

[1]Division of General Internal Medicine, Department of Medicine, Baltimore, MD, USA

[2]Division of Nephrology, Department of Medicine, Baltimore, MD, USA

[3]Johns Hopkins Evidence-based Practice Center, Baltimore, MD, USA

[4]Johns Hopkins Bayview Medical Center, 301 Mason F. Lord Drive, Suite 2500, Baltimore, MD, 21224, USA

[5]Department of Epidemiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA

[6]Division of Pediatric Nephrology, Department of Pediatrics, Baltimore, MD, USA

关键词: Health services research;    Evidence-based practice;    Chronic kidney disease;   

Others  :  1083139
DOI  :  10.1186/1471-2369-13-74

 received in 2012-04-06, accepted in 2012-06-29,  发布年份 2012

【 摘 要 】

Systematic reviews comparing the effectiveness of strategies to prevent, detect, and treat chronic kidney disease are needed to inform patient care. We engaged stakeholders in the chronic kidney disease community to prioritize topics for future comparative effectiveness research systematic reviews. We developed a preliminary list of suggested topics and stakeholders refined and ranked topics based on their importance. Among 46 topics identified, stakeholders nominated 18 as ‘high’ priority. Most pertained to strategies to slow disease progression, including: (a) treat proteinuria, (b) improve access to care, (c) treat hypertension, (d) use health information technology, and (e) implement dietary strategies. Most (15 of 18) topics had been previously studied with two or more randomized controlled trials, indicating feasibility of rigorous systematic reviews. Chronic kidney disease topics rated by stakeholders as ‘high priority’ are varied in scope and may lead to quality systematic reviews impacting practice and policy.

【 授权许可】

   
2012 Crews et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1 .

【 参考文献 】

• [1]Mehrotra R: Bridging the care gap around dialysis initiation: Is CKD education part of the solution? Am J Kidney Dis 2011, 58(2):160-161.
• [2]Smith DH, Thorp ML: Nurse-coordinated care in CKD: time for translation into practice? Clin J Am Soc Nephrol 2011, 6(6):1229-1231.
• [3]Pauly RP, Tonelli M: Predicting development of CKD in the general population–early days in a rapidly evolving field. Am J Kidney Dis 2011, 57(6):805-807.
• [4]Litvin CB, Nietert PJ, Wessell AM, Jenkins RG, Ornstein SM: Recognition and management of CKD in primary care. Am J Kidney Dis 2011, 57(4):646-647.
• [5]Ikizler TA: CKD classification: time to move beyond KDOQI. J Am Soc Nephrol 2009, 20(5):929-930.
• [6]Fink JC, Chertow GM: Medication errors in chronic kidney disease: one piece in the patient safety puzzle. Kidney Int 2009, 76(11):1123-1125.
• [7]Wasse H, McClellan WM: Increasing physician knowledge about the diagnosis and management of CKD: how can we help primary care providers? Am J Kidney Dis 2009, 54(2):187-190.
• [8]Federal Coordinating Council for Comparative Effectiveness Research: Report to the President and the Congress. Department of Health and Human Services, Washington, DC; June 2009. Accessed January 10, 2012, at http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf webcite
• [9]Agency for Healthcare Research and Quality: Recovery Act Awards. Rockville, MD; September 2010. Accessed February 6, 2012, at http://www.ahrq.gov/fund/recoveryawards/ webcite
• [10]Brewer NT, Salz T, Lillie SE: Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007, 146(7):502-510.
• [11]Agency for Healthcare Research and Quality: The Effective Health Care Program Stakeholder Guide 2011. Rockville, MD; July 2011. Accessed February 6, 2012, at http://www.ahrq.gov/clinic/epcpartner/stakeholderguide/stakeholdr.pdf webcite
• [12]Patient-Centered Outcomes Research Institute (PCORI). Washington, DC; Accessed February 1, 2012, at http://www.pcori.org/ webcite
• [13]National Kidney Foundation: KDOQI Guidelines and Commentaries. 2009. Accessed January 20, 2012, at http://www.kidney.org/professionals/kdoqi/guidelines_commentaries.cfm webcite
• [14]London G, Coyne D, Hruska K, Malluche HH, Martin KJ: The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification. Clin Nephrol 2010, 74(6):423-432.
• [15]Agency for Healthcare Research and Quality Effective Health Care Program: Screening for and Management of Chronic Kidney Disease Stages 1–3. July 2010. Accessed December 20, 2012, at http://www.effectivehealthcare.ahrq.gov/ehc/products/163/480/CKD%20Protocol%20with%20logos%207%2020%2010.pdf webcite